Nanbin Liu

454 total citations · 1 hit paper
14 papers, 339 citations indexed

About

Nanbin Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nanbin Liu has authored 14 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Nanbin Liu's work include RNA modifications and cancer (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer-related molecular mechanisms research (3 papers). Nanbin Liu is often cited by papers focused on RNA modifications and cancer (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer-related molecular mechanisms research (3 papers). Nanbin Liu collaborates with scholars based in China and United States. Nanbin Liu's co-authors include Ran Qi, Yixuan Bai, Baomin Shi, Kun Li, Yufeng Wang, Rui Lin, Hui Wang, Zhongyan Liu, Xiuyan Wang and Baomin Shi and has published in prestigious journals such as Frontiers in Pharmacology, Redox Biology and Cancers.

In The Last Decade

Nanbin Liu

11 papers receiving 337 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs

2023 190 citations Ran Qi, Yixuan Bai et al. Drug Resistance Updates profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nanbin Liu China	6	247	211	102	74	32	14	339
Jingde Chen China	10	279 1.1×	128 0.6×	78 0.8×	90 1.2×	44 1.4×	21	370
Maria Pia Patrizio Italy	7	149 0.6×	100 0.5×	73 0.7×	69 0.9×	31 1.0×	11	250
Jingbing Lou China	8	188 0.8×	136 0.6×	73 0.7×	79 1.1×	75 2.3×	12	316
Jiguang Han China	10	216 0.9×	214 1.0×	70 0.7×	99 1.3×	37 1.2×	18	372
Qingyong Xu China	9	267 1.1×	179 0.8×	50 0.5×	53 0.7×	34 1.1×	10	354
Hang Fan China	7	283 1.1×	197 0.9×	54 0.5×	69 0.9×	39 1.2×	8	339
Zeli Yin China	8	217 0.9×	199 0.9×	62 0.6×	100 1.4×	84 2.6×	11	371
Weiqing Lu China	5	185 0.7×	104 0.5×	38 0.4×	96 1.3×	48 1.5×	8	278
Nan Huo China	8	190 0.8×	126 0.6×	47 0.5×	76 1.0×	43 1.3×	8	302
Nanhang Lu China	7	263 1.1×	151 0.7×	48 0.5×	86 1.2×	39 1.2×	16	357

Countries citing papers authored by Nanbin Liu

Since Specialization

Citations

This map shows the geographic impact of Nanbin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanbin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanbin Liu more than expected).

Fields of papers citing papers by Nanbin Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanbin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanbin Liu. The network helps show where Nanbin Liu may publish in the future.

Co-authorship network of co-authors of Nanbin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Nanbin Liu. A scholar is included among the top collaborators of Nanbin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanbin Liu. Nanbin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Li, Zeyu, Fei Du, Nanbin Liu, et al.. (2025). Macrophage DHX34 as a negative regulator of the CX3CL1–CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma. International Immunopharmacology. 169. 116014–116014.

Huang, Li‐Min, Zeyu Li, Qian Wang, et al.. (2025). DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC. Neoplasia. 67. 101198–101198. 1 indexed citations

Zeng, Kaixuan, Na Huang, Nanbin Liu, et al.. (2024). LACTB suppresses liver cancer progression through regulation of ferroptosis. Redox Biology. 75. 103270–103270. 11 indexed citations

Liu, Nanbin, Qian Wang, Peng‐Peng Zhu, et al.. (2024). DHX34 as a promising biomarker for prognosis, immunotherapy and chemotherapy in Pan-Cancer: A Comprehensive Analysis and Experimental Validation. Journal of Cancer. 15(20). 6594–6615. 3 indexed citations

Qi, Ran, Yixuan Bai, Kun Li, et al.. (2023). Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resistance Updates. 68. 100960–100960. 190 indexed citations breakdown →

Liu, Nanbin, Hailong Zhang, Chunli Zhang, et al.. (2023). DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC. Cancers. 15(21). 5228–5228. 3 indexed citations

Li, Kun, et al.. (2023). Acute diffuse peritonitis secondary to a seminal vesicle abscess: A case report. World Journal of Clinical Cases. 11(3). 645–654.

Li, Kun, et al.. (2022). Relationship between postoperative biliary stricture and clinical characteristics of patients with benign and malignant biliary diseases.. Videosurgery and Other Miniinvasive Techniques. 18(1). 117–127.

Wei, Yuhua, Yufeng Wang, Nanbin Liu, et al.. (2022). A FAK Inhibitor Boosts Anti-PD1 Immunotherapy in a Hepatocellular Carcinoma Mouse Model. Frontiers in Pharmacology. 12. 820446–820446. 21 indexed citations

10.

Wang, Bingyi, Yan Xu, Nanbin Liu, et al.. (2021). Human Mesenchymal Stem Cell-Derived Exosomal microRNA-143 Promotes Apoptosis and Suppresses Cell Growth in Pancreatic Cancer via Target Gene Regulation. Frontiers in Genetics. 12. 581694–581694. 31 indexed citations

11.

Qi, Ran, Yixuan Bai, Yuhua Wei, Nanbin Liu, & Baomin Shi. (2021). The role of non-coding RNAs in ferroptosis regulation. Journal of Trace Elements in Medicine and Biology. 70. 126911–126911. 20 indexed citations

12.

Li, Kun, et al.. (2021). Asymptomatic gastric adenomyoma and heterotopic pancreas in a patient with pancreatic cancer: A case report and review of the literature. World Journal of Clinical Cases. 9(27). 8147–8156. 3 indexed citations

13.

Chen, Quanning, et al.. (2020). Synchronous hepatocellular carcinoma and gallbladder adenocarcinoma with neuroendocrine differentiation: a case report and literature review. BMC Surgery. 20(1). 246–246. 4 indexed citations

14.

Xu, Yan, et al.. (2020). Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells. Aging. 12(19). 19660–19676. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact